Perkins Coie Trust Company’s Edwards Lifesciences EW Stock Holding History

Perkins Coie Trust Company’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$166K	Sell	1,835 -15	-0.8%	-$1.26K	0.03%	117
2026 Q1	$148K	Sell	1,850 -19	-1%	-$1.57K	0.03%	118
2025 Q4	$159K	Sell	1,869 -206	-10%	-$16.9K	0.03%	117
2025 Q3	$161K	Sell	2,075 -173	-8%	-$13.5K	0.03%	115
2025 Q2	$176K	Hold	2,248	–	–	0.03%	121
2025 Q1	$163K	Hold	2,248	–	–	0.04%	119
2024 Q4	$166K	Sell	2,248 -260	-10%	-$18.2K	0.04%	117
2024 Q3	$166K	Hold	2,508	–	–	0.04%	119
2024 Q2	$232K	Buy	+2,508	New	+$222K	0.05%	96
2023 Q4	–	Sell	-65	Closed	-$4.5K	–	400
2023 Q3	$4.5K	Buy	+65	New	+$5.22K	﹤0.01%	284
2020 Q3	–	Sell	-9	Closed	-$1K	–	273
2020 Q2	$1K	Hold	9	–	–	﹤0.01%	268
2020 Q1	$1K	Buy	+9	New	+$649	﹤0.01%	296

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Perkins Coie Trust Company's EW Position: Q2 2026 in Review

Perkins Coie Trust Company reduced its Edwards Lifesciences (EW) stake by 0.81% in Q2 2026, selling an estimated $1.26K and leaving 1,835 shares worth $166K. The position accounts for 0.03% of the portfolio, ranked #117.

Perkins Coie Trust Company first reported a position in EW in Q1 2020 and has held it in 12 quarters since. The position peaked at $232K in Q2 2024. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Perkins Coie Trust Company held 1,835 shares of Edwards Lifesciences worth $166K as of Q2 2026.
Perkins Coie Trust Company sold 15 Edwards Lifesciences shares in Q2 2026, an estimated $1.26K.
Edwards Lifesciences made up 0.03% of Perkins Coie Trust Company's portfolio in Q2 2026, its #117 holding.
Perkins Coie Trust Company first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 12 quarters since.
Perkins Coie Trust Company's Edwards Lifesciences position peaked at $232K in Q2 2024.
372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.